Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study
Journal of Advances in Medical and Biomedical Research · 2025
DOI: 10.30699/jambr.33.157.149 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Advances in Medical and Biomedical Research, 2025. Verfasst von Arman Ahmadzadeh und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ahmadzadeh, A., Farsad, F., Rahaei, A., Emam, M. M., Gachkar, L., & Shahri, E. S. (2025). Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study. Journal of Advances in Medical and Biomedical Research. https://doi.org/10.30699/jambr.33.157.149
Vancouver
Ahmadzadeh A, Farsad F, Rahaei A, Emam MM, Gachkar L, Shahri ES. Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study. Journal of Advances in Medical and Biomedical Research. 2025. doi:10.30699/jambr.33.157.149
BibTeX
@article{Ahmadzadeh2025,
author = {Ahmadzadeh, Arman and Farsad, Faraneh and Rahaei, Alireza and Emam, Mohammad Mehdi and Gachkar, Latif and Shahri, Elnaz Shafighi},
title = {Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study},
journal = {Journal of Advances in Medical and Biomedical Research},
year = {2025},
doi = {10.30699/jambr.33.157.149}
}
EUVIMED